42 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Air T, Inc. AIRT gained 85.6% to $18.10 after the company announced plans to form a new aircraft equity vehicle. Air T will form a new aircraft asset management business to be called Contrail Aircraft Management, and a new aircraft capital joint venture to be called Contrail Fund II.
• Avinger, Inc. AVGR jumped 79.2% to $0.6201 after the company reported annual meeting results. The company’s stock climbed over 13% on Wednesday.
• SIFCO Industries, Inc. SIF jumped 62.8% to $6.35 after the company reported a strong rise in its earnings for the fourth quarter.
• Senseonics Holdings, Inc. SENS shares climbed 50.3% to $0.9722 after the company lifted its sales guidance for the fourth quarter. The company said it now expects Q4 net sales of $3.5 million, versus prior forecast of $2.5 million.
• Neoleukin Therapeutics, Inc. NLTX gained 33.6% to $14.39. Neoleukin Therapeutics Director Julian Baker reported the purchase of 981,529 shares at an average price of $15.25 per share in form 4 filing on Wednesday.
• Gevo, Inc. GEVO gained 27.4% to $3.71. Gevo, on Monday, announced it has optioned the right to purchase land near Lake Preston, SD, and has met the initial milestone to secure control of a site by the end of this year.
• BIOLASE, Inc.. BIOL jumped 21.9% to $0.4029. BIOLASE, last week, announced a collaboration with BMW Performance Center West.
• Triterras, Inc. TRIT climbed 20.8% to $14.57 after climbing over 16% on Wednesday. Triterras recently provided Q3 net revenue and net income projections and reiterated its FY2020 guidance.
• Northern Star Acquisition Corp. STIC jumped 18.1% to $17.52 after jumping over 6% on Wednesday.
• Phoenix Tree Holdings Limited DNK gained 16.9% to $3.66.
• Petros Pharmaceuticals, Inc. PTPI surged 14.1% to $4.28.
• Odonate Therapeutics, Inc. ODT shares rose 14% to $17.95. Odonate Therapeutics CFO Hearne reported the purchase of 275,784 shares at an average price of $15.16 per share in Form 4 filing.
• One Stop Systems, Inc. OSS surged 13.8% to $3.61.
• Bridgetown Holdings Limited BTWN gained 13.6% to $16.35 after gaining over 3% on Wednesday.
• 908 Devices Inc. MASS shares surged 12.8% to $69.72. 908 Devices priced its IPO at $20 per share last week.
• HC2 Holdings, Inc. HCHC rose 11.9% to $3.67. HC2 recently received a non-binding indication of interest for the potential acquisition of the company's insurance segment from Continental General Holdings.
• Monopar Therapeutics Inc, MNPR gained 11.7% to $7.72 after climbing 15% on Wednesday. Monopar recently announced the issuance of U.S. patent covering compositions of matter for a novel family of camsirubicin analogs.
• StoneMor Inc. STON jumped 10.5% to $2.85 after the company said it regained compliance with NYSE listing standards.
• SG Blocks, Inc. SGBX rose 6.8% to $5.21. SG Blocks, last week, said its sees FY21 gross revenue of $20 million.
• Tonix Pharmaceuticals Holding Corp. TNXP surged 6.2% to $0.7008 after gaining over 15% on Wednesday. Tonix Pharma reported completion of purchase of 44-acre site in Hamilton, Montana for construction of vaccine development and commercial scale manufacturing facility.

Check out these big penny stock gainers and losers

Losers

• Jaguar Health, Inc. JAGX shares declined 32.3% to $0.7253. Jaguar Health shares jumped 170% on Wednesday after the company signed an agreement with a secured lender involving the $6 million sale of royalty interest in Mytesi royalties.
• Staffing 360 Solutions, Inc. STAF shares tumbled 24.6% to $0.6408 after the company reported pricing of $2.5 million public offering of common stock.
• HighPeak Energy, Inc. HPK shares dipped 23% to $14.83.
• Ocugen, Inc. OCGN fell 22.5% to $2.0150. Ocugen shares climbed 223% on Wednesday after the company announced it will convene its Meeting of Stockholders on Dec. 23 to modify a proposal, decreasing the proposed aggregate number of shares of common stock that the Company would be authorized to issue.
• Second Sight Medical Products, Inc. EYES dropped 21.6% to $2.5250 after surging around 15% on Wednesday.
• AgEagle Aerial Systems, Inc. UAVS fell 20.9% to $6.27 after climbing around 17% on Wednesday.
• Future FinTech Group Inc. FTFT dropped 16.3% to $1.90 after reporting an $8 million registered direct offering.
• Energous Corporation WATT fell 16.3% to $2.125 after jumping over 36% on Wednesday. Energous, on Tuesday, named current board director Dan Fairfax as chairman of the board.
• Eos Energy Enterprises, Inc. EOSE shares declined 16% to $19.42 after jumping around 45% on Wednesday.
• Wunong Net Technology Company Limited WNW fell 14.6% to $48.67 after climbing around 39% on Wednesday.
• Alibaba Group Holding Limited BABA dropped 14.2% to $219.83 after Chinese regulators launched an antitrust investigation into the company.
• fuboTV Inc. FUBO fell 14.2% to $44.91 after LightShed Partners initiated the stock with Sell rating and $8 price target, calling the stock a 'compelling short.' BMO Capital, on Wednesday, downgraded the stock from Outperform to Market Perform and announced a $50 price target.
• Boqii Holding Limited BQ tumbled 13.3% to $6.24.
• Jupiter Wellness, Inc. JUPW dipped 12% to $4.92.
• Foresight Autonomous Holdings Ltd. FRSX fell 12% to $5.06. Foresight Autonomous shares climbed 78% on Wednesday on continued strength, which appears to be in reaction to reports of Apple working on a self-driving EV. Foresight's technology can be used in autonomous vehicles.
• Cyclacel Pharmaceuticals, Inc. CYCC dipped 11.2% to $7.50.
• Altimmune, Inc. ALT fell 9.4% to $11.44 after the company reported that the FDA has issued a clinical hold on its Investigational New Drug application for its intranasal Covid-19 vaccine candidate, AdCOVID.
• Vislink Technologies, Inc. VISL fell 9.3% to $1.65 following a 9% gain on Wednesday.
• Pharming Group N.V. PHAR fell 9% to $15.21.
• FireEye, Inc. FEYE fell 9% to $21.88, selling off following a recent surge in cybersecurity names after a SolarWinds security breach.
• Onconova Therapeutics, Inc. ONTX shares declined 7.4% to $0.4669 after climbing over 17% on Wednesday. Onconova Therapeutics, on Monday, reported the FDA permission for study to proceed under its investigational new drug application for multi-kinase CDK4/6 inhibitor ON 123300.
• Gold Resource Corporation GORO fell 6% to $3.44. Gold Resource, last week, approved a spin-off of Fortitude Gold Corporation.